$70 Million Raised for Neuron Replacement Therapy Techniques to Treat Parkinson’s

$70 Million Raised for Neuron Replacement Therapy Techniques to Treat Parkinson’s
Aspen Neuroscience has raised $70 million to advance the development of  Parkinson’s disease therapies using patients’ own cells. The products, ANPD001 and ANPD002, are the first-ever Parkinson’s treatments designed to use a patient’s own cells as a replacement to restore neuronal function and to modify disease progression. This approach is referred to as an autologous neuron replacement therapy. “Our mission ... read more
Source: Parkinson’s News TodayPublished on 2020-04-09By David Melamed, PhD